VCEL
Vericel Corporation$35.86-1.06 (-2.87%)Prev Close$36.92·MCap$1.71B·P/E119.85·Vol557.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
20
$5.29M
◆
Net Activity
Net Seller
$5.29M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Vericel Corporation (VCEL) has been exclusively selling, with 0 insider purchases totaling $0.00 and 20 insider sales totaling $5.29M. The most recent insider transaction was by Hopper Jonathan Mark (officer: Chief Medical Officer), who sold $121.5K worth of shares on Apr 6, 2026. Vericel Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.71B.
VCEL Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
| Nov 25, 2024 | ZERBE ROBERT L MD | Sell | 2,500 | $60.00 | $150.0K | 26,595 | |
| Nov 15, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $54.75 | $1.92M | 220,937 |
| Nov 15, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.54 | $388.8K | 11,900-37% | |
| Nov 13, 2024 | ZERBE ROBERT L MD | Sell | 5,000 | $56.25 | $281.3K | 26,595 | |
| Oct 18, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $40.86 | $1.43M | 220,937 |
| Oct 18, 2024 | GILMAN STEVEN C | Sell | 5,833 | $41.36 | $241.3K | 11,000-35% | |
| Oct 4, 2024 | GILMAN STEVEN C | Sell | 5,833 | $40.35 | $235.4K | 11,000-35% | |
| Oct 2, 2024 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 568 | $41.90 | $23.8K | 1,124-34% |
| Sep 20, 2024 | GILMAN STEVEN C | Sell | 5,834 | $45.54 | $265.7K | 11,000-35% | |
| Sep 13, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $43.64 | $1.53M | 220,937 |
| Sep 5, 2024 | GILMAN STEVEN C | Sell | 5,000 | $48.58 | $242.9K | 11,000-31% | |
| Sep 5, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.83 | $498.3K | 58,229 |
| Aug 16, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $45.71 | $1.60M | 220,937 |
| Aug 9, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $45.94 | $321.6K | 11,900-37% |
Showing 1–50 of 101
1 / 3
VCEL Insider Buying Activity
The following table shows recent insider purchases of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
No insider buying activity found for VCEL in the last 12 months.
VCEL Insider Selling Activity
The following table shows recent insider sales of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
| Nov 25, 2024 | ZERBE ROBERT L MD | Sell | 2,500 | $60.00 | $150.0K | 26,595 | |
| Nov 15, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $54.75 | $1.92M | 220,937 |
| Nov 15, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.54 | $388.8K | 11,900-37% | |
| Nov 13, 2024 | ZERBE ROBERT L MD | Sell | 5,000 | $56.25 | $281.3K | 26,595 | |
| Oct 18, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $40.86 | $1.43M | 220,937 |
| Oct 18, 2024 | GILMAN STEVEN C | Sell | 5,833 | $41.36 | $241.3K | 11,000-35% | |
| Oct 4, 2024 | GILMAN STEVEN C | Sell | 5,833 | $40.35 | $235.4K | 11,000-35% | |
| Oct 2, 2024 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 568 | $41.90 | $23.8K | 1,124-34% |
| Sep 20, 2024 | GILMAN STEVEN C | Sell | 5,834 | $45.54 | $265.7K | 11,000-35% | |
| Sep 13, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $43.64 | $1.53M | 220,937 |
| Sep 5, 2024 | GILMAN STEVEN C | Sell | 5,000 | $48.58 | $242.9K | 11,000-31% | |
| Sep 5, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.83 | $498.3K | 58,229 |
| Aug 16, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $45.71 | $1.60M | 220,937 |
| Aug 9, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $45.94 | $321.6K | 11,900-37% |
VCEL Insiders
Similar Stocks to VCEL
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B